BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9515748)

  • 1. Otolaryngologic manifestations of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC
    Scand J Gastroenterol Suppl; 1998; 225():24-8. PubMed ID: 9515748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ear, nose and throat and respiratory manifestations of gastro-esophageal reflux disease: an increasing conundrum.
    Richter JE
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):837-45. PubMed ID: 15316405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraoesophageal manifestations of gastro-oesophageal reflux.
    Poelmans J; Tack J
    Gut; 2005 Oct; 54(10):1492-9. PubMed ID: 16162955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of gastroesophageal reflux and otolaryngologic disorders.
    Cote DN; Miller RH
    Compr Ther; 1995; 21(2):80-4. PubMed ID: 7743773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supra-oesophageal manifestations of gastro-oesophageal reflux disease.
    Groen JN; Smout AJ
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1339-50. PubMed ID: 14624158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ENT manifestations of gastroesophageal reflux disease (GERD)].
    Watanabe Y
    Nihon Rinsho; 2004 Aug; 62(8):1533-6. PubMed ID: 15344546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease.
    Richter JE
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():70-80. PubMed ID: 16042662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The otolaryngological manifestations of gastroesophageal reflux disease].
    Tall A; Diop EM
    Dakar Med; 2008; 53(2):142-9. PubMed ID: 19634550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.
    Koufman JA
    Laryngoscope; 1991 Apr; 101(4 Pt 2 Suppl 53):1-78. PubMed ID: 1895864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
    Monés J
    Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal reflux disease and the larynx.
    Vaezi MF
    J Clin Gastroenterol; 2003 Mar; 36(3):198-203. PubMed ID: 12590228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is ambulatory 24-h dual-probe pH monitoring useful in suspected ENT manifestations of GERD?
    Sermon F; Vanden Brande S; Roosens B; Mana F; Deron P; Urbain D
    Dig Liver Dis; 2004 Feb; 36(2):105-10. PubMed ID: 15002816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].
    Issing WJ; Gross M; Tauber S
    Laryngorhinootologie; 2001 Aug; 80(8):464-9. PubMed ID: 11552426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laryngopharyngeal manifestations of gastroesophageal reflux disease.
    Olson NR
    Otolaryngol Clin North Am; 1991 Oct; 24(5):1201-13. PubMed ID: 1754220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ENT manifestations of gastroesophageal reflux].
    Rosanowski F; Eysholdt U
    Internist (Berl); 2003 Jan; 44(1):63-7. PubMed ID: 12677707
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gastroesophageal reflux involvement in ENT disorders].
    Drug VL; Cobzeanu D; Papaghiuc C; Ciochină P; Gogălniceanu P; Bugioianoun C; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):220-2. PubMed ID: 16607774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
    Issing WJ; Tauber S; Folwaczny C; Reichel O
    Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of supraesophageal manifestations in patients with gastroesophageal erosive and non-erosive reflux disease].
    Aguero GC; Lemme EM; Alvariz A; Carvalho BB; Schechter RB; Abrahão L
    Arq Gastroenterol; 2007; 44(1):39-43. PubMed ID: 17639181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The otolaryngologic manifestations of gastroesophageal reflux: when is a pH study indicated?
    Bouchard S; Lallier M; Yazbeck S; Bensoussan A
    J Pediatr Surg; 1999 Jul; 34(7):1053-6. PubMed ID: 10442586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.